IMNN (Imunon) Buyback Yield %: -168.49 (As of Jul. 03, 2026)


IMNN Imunon Inc IMNN
26 GF Score
Price $1.91
! 3 Warning Signs
View Full Analysis

What is Imunon Buyback Yield %?

Imunon IMNN +1.60% 26 Buyback Yield % is -168.49 as of Jul. 03, 2026. GuruFocus rates IMNN with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 744 Biotechnology companies, Imunon ranks worse than 93.68% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Imunon's current buyback yield was -168.49%.

Imunon Buyback Yield % Historical Data

* Premium members only.

The historical data trend for Imunon's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imunon Buyback Yield % Chart

Imunon Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -98.11 -58.25 -37.82 -57.18 -104.59

Imunon Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.69 -16.53 -43.33 -104.59 -117.25

IMNN vs KAPA, HCWB, CURX: Buyback Yield % Comparison

For the Biotechnology subindustry, Imunon's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imunon Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Imunon's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Imunon's Buyback Yield % falls into.


IMNN
26GF Score
Imunon Inc IMNN
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Imunon Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Imunon's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 13.628) / 13.0302
=-104.59%

Imunon's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 13.523) / 11.53362
=-117.25%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -168.49 mean?
Imunon (IMNN) has a Buyback Yield % of -168.49 as of Jul. 03, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Imunon and its competitors. According to the industry distribution chart, Imunon ranks #697 out of 744 companies in the Biotechnology industry, placing it in the top 93.7%.
Is Imunon's Buyback Yield % too high?
Imunon's current Buyback Yield % is -168.49. Based on the distribution chart, Imunon ranks #697 out of 744 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Imunon has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Imunon's Buyback Yield % compare to KAPA and HCWB?
According to the Biotechnology industry distribution chart, Imunon ranks #697 out of 744 companies for Buyback Yield %. This places Imunon in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Imunon and its competitors. Imunon's current Buyback Yield % is -168.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imunon stock overvalued right now?
Imunon (IMNN) has a current Buyback Yield % of -168.49. The current Buyback Yield % is -168.49. Imunon's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Imunon (IMNN), the current Buyback Yield % is -168.49 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imunon Business Description

Other Exchanges CBO0:Germany
Address 997 Lenox Drive, Suite 100, Lawrenceville, NJ, USA, 08648
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.
26GF Score

Get the complete analysis for IMNN

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.91
Price